ArticleScientific reports2025
RNAdvisor 2: A unified platform for RNA 3D model quality assessment using metrics, scoring functions, and meta-metrics.
Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
RNA is a molecule that performs critical roles in cellular biology, with its function closely dependent on its three-dimensional conformation. Predicting and evaluating RNA 3D structures remains a significant challenge in the field. Although many metrics and scoring functions have been developed to assess structural quality, each offers a different perspective, and no single method has emerged as a definitive standard. To address this, we previously introduced RNAdvisor, a comprehensive and automated software platform to evaluate 3D RNA structures using a wide range of existing quality metrics and scoring functions. This work presents RNAdvisor2, an extended and improved version of the tool. RNAdvisor 2 introduces a web server designed to enhance accessibility and usability for the broader research community. This release includes new scoring functions and integrates the novel concepts of meta-metrics and meta-scoring functions, which unify diverse evaluation criteria into more robust indicators of RNA structure quality. Additionally, the command-line tool has been improved and optimized for greater stability and extensibility, supporting scalable and maintainable future development. The web server, tool and its source code are freely available on the EvryRNA platform: https://evryrna.ibisc.univ-evry.fr .
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.